COCH — Envoy Medical, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1840877 ·
Last close
$0.70
Market Cap
$53.82M
52W High
$0.95
52W Low
$0.60
ADV30
131,079
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 39,000 | -274,000 | -5,959,000 | -4,351,000 | 29,822,000 | 25,251,000 | 19,270,000 |
| Dec 2025 | 75,000 | -136,000 | -6,385,000 | -6,586,000 | 8,558,000 | 3,739,000 | 20,325,000 |
| Sep 2025 | 42,000 | -161,000 | -5,708,000 | -6,482,000 | 8,181,000 | 3,556,000 | 15,712,000 |
| Jun 2025 | 78,000 | -156,000 | -5,070,000 | -5,690,000 | 9,900,000 | 5,287,000 | 39,759,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-18,201,000
Investing CF
$-179,000
Financing CF
$16,633,000
CapEx
$-794,000
Dividends Paid
$-1,819,000
Buybacks
—
EPS Diluted TTM
$-1.35
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-313,396,000
Inventory
$1,546,000
Receivables
$53,000
ST Investments
—
EBIT TTM
$-22,166,000
Pretax Income TTM
$-23,756,000
Interest Exp TTM
$1,590,000
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$234,000
EBITDA
$-22,618,000
Free Cash Flow
$-7,911,875
Enterprise Value
$30,146,706
Total Cash
$25,251,000
Total Debt
$889,000
Shares Out
76,881,110
Trailing EPS
$-1.02
Book Value
$0.14
ROE
—
ROA
-71.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 241,000 | -22,270,000 | -23,756,000 | 8,558,000 | 20,325,000 | — | -18,201,000 |
| Dec 2024 | 225,000 | -19,256,000 | -20,795,000 | 11,538,000 | 30,380,000 | — | -17,949,000 |
| Dec 2023 | 316,000 | -18,359,000 | -29,922,000 | 8,271,000 | 10,047,000 | — | -17,091,000 |
| Dec 2022 | 237,000 | -8,706,000 | -15,923,000 | 2,556,000 | 38,751,000 | — | -8,805,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.30
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| POCI | PRECISION OPTICS CORPORATION, INC. | $54.40M | $4.97 | — |
| DRIO | DarioHealth Corp. | $54.92M | $7.51 | — |
| SRTS | Sensus Healthcare, Inc. | $52.68M | $3.20 | — |
| IDXG | INTERPACE BIOSCIENCES, INC. | $49.86M | $1.80 | — |
| BEAT | HeartBeam, Inc. | $49.57M | $0.89 | — |
News headlines (Yahoo Finance, 1h cache)
Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology
2026-05-20 12:30 · Yahoo
Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant
2026-05-11 12:00 · Yahoo
TransMedics (TMDX) Q1 Earnings and Revenues Miss Estimates
2026-05-05 22:05 · Yahoo
Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant
2026-04-28 12:30 · Yahoo
Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant
2026-04-22 12:00 · Yahoo
Envoy Medical Appoints Chas McKhann to Board of Directors
2026-04-16 12:00 · Yahoo
Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant
2026-04-01 12:00 · Yahoo
Envoy Medical Reports Full Year 2025 Financial Results
2026-03-23 12:30 · Yahoo
Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant
2026-03-11 12:00 · Yahoo
Envoy Medical Regains Compliance with Nasdaq Listing Requirement
2026-02-24 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.